| Objective: To observe the clinical efficacy of Mao’s Shengxian Decoction in treating congestive heart failure syndrome of ischemic cardiomyopathy with zongqi depression and blood stasis water stopping,and objectively evaluate the effectiveness and safety of Mao’s Shengxian Decoction,so as to provide new effective prescriptions for clinical treatment of congestive heart failure syndrome of ischemic cardiomyopathy with zongqi depression and blood stasis water stopping.Methods:Sixty patients who met the criteria were randomly divided into treatment group and control group according to the principle of randomized control.The control group was treated with routine western medicine,while the treatment group was treated with Mao’s Shengxian Decoction on the basis of the control group.The changes of TCM syndromes score,TCM syndromes efficacy,Lee’s heart failure score,left ventricular ejection fraction,NT-pro BNP,Minnesota heart failure quality of life,heart function classification before and after treatment were observed,and the safety of patients during treatment was evaluated.Result: By comparing the data of two groups before and after treatment,the scores of TCM syndromes,the curative effect of TCM syndromes,Lee’s heart failure score,left ventricular ejection fraction,NT-pro BNP,Minnesota heart failure quality of life and heart function grading of the two groups were significantly improved after treatment(P < 0.05),and the improvement of the treatment group was better than that of the control group(P < 0.05).Conclusion: Mao’s Shengxian Decoction can significantly improve the clinical symptoms of ischemic cardiomyopathy patients with congestive heart failure and stagnation of blood stasis and water,without obvious adverse reactions,which is worthy of clinical promotion. |
PDF Full Text Request